Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Acta Biomaterialia|June 22, 2011
Chemical surface modification of parylene C for enhanced protein immobilization and cell proliferationChanghong Zhang, Mark E Thompson, Frank S Markland, et al.Veterinary and Comparative Oncology|May 16, 2025
Potent Therapeutic Activity of NEO212 in Preclinical Models of Human and Canine Leukaemia and LymphomaThomas C Chen, Steve Swenson, Thu Zan Thein, et al.Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|November 20, 2012
Reversal of thienopyridine-induced platelet dysfunction following desmopressin administrationMichael Levine, Steve Swenson, Taylor McCormick, et al.Cancers|December 23, 2022
NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their TumorigenicityThomas C Chen, Radu O Minea, Steve Swenson, et al.Amino Acids|October 18, 2019
Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancerHossein Jadvar, Kai Chen, Ryan Park, et al.Journal of Neurosurgery|March 16, 2019
Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma modelsWeijun Wang, Steve Swenson, Hee-Yeon Cho, et al.Molecules (Basel, Switzerland)|November 11, 2018
A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in MiceSteve Swenson, Radu O Minea, Cao Duc Tuan, et al.Journal of Economic Entomology|July 2, 2025
Semiochemical interruption of Dendroctonus rufipennis (Coleoptera: Curculionidae) in Alaska and Colorado, U.SJackson P Audley, Christopher J Fettig, Jason E Moan, et al.Cancers|March 13, 2024
Activation of Epstein-Barr Virus' Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and TemozolomideHannah Hartman-Houstman, Steve Swenson, Radu O Minea, et al.Pageof 2